HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can Zhang Selected Research

CPU86017-RS

12/2013Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation.
4/2012CPU86017-RS attenuate hypoxia-induced testicular dysfunction in mice by normalizing androgen biosynthesis genes and pro-inflammatory cytokines.
1/2012Endoplasmic reticulum stress mediating downregulated StAR and 3-beta-HSD and low plasma testosterone caused by hypoxia is attenuated by CPU86017-RS and nifedipine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Can Zhang Research Topics

Disease

95Neoplasms (Cancer)
05/2024 - 03/2008
53Alzheimer Disease (Alzheimer's Disease)
04/2024 - 08/2007
23Inflammation (Inflammations)
12/2023 - 01/2016
21Infections
04/2024 - 01/2017
12Cognitive Dysfunction
02/2024 - 01/2019
11Breast Neoplasms (Breast Cancer)
04/2024 - 10/2012
11Neuroinflammatory Diseases
02/2024 - 01/2019
10Hypoxia (Hypoxemia)
10/2023 - 01/2012
10Glioma (Gliomas)
12/2017 - 02/2014
9Viremia
04/2024 - 01/2019
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2023 - 02/2020
8Pain (Aches)
01/2023 - 01/2018
7Osteosarcoma (Osteogenic Sarcoma)
05/2024 - 03/2018
7Syringomyelia (Morvan's Disease)
02/2024 - 01/2020
7Wounds and Injuries (Trauma)
01/2024 - 01/2012
7Neoplasm Metastasis (Metastasis)
10/2021 - 02/2014
7Amyloid Plaque
01/2020 - 09/2010
6Carcinoma (Carcinomatosis)
05/2024 - 02/2003
6Dementia (Dementias)
11/2023 - 11/2014
6Virus Diseases (Viral Diseases)
01/2023 - 01/2019
6Carcinogenesis
01/2020 - 10/2011
6Lung Neoplasms (Lung Cancer)
10/2018 - 03/2008
5Glioblastoma (Glioblastoma Multiforme)
04/2024 - 02/2014
5Amyloidosis
02/2024 - 05/2013
5Non-alcoholic Fatty Liver Disease
12/2023 - 08/2015
5Residual Neoplasm
05/2023 - 12/2021
4Parkinson Disease (Parkinson's Disease)
05/2024 - 01/2021
4Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 05/2009
4Insulin Resistance
12/2023 - 01/2018
4Obesity
12/2023 - 01/2017
4Spinal Cord Injuries (Spinal Cord Injury)
12/2023 - 01/2021
4Disease Progression
11/2023 - 01/2018
4Fibrosis (Cirrhosis)
10/2023 - 02/2018
4Liver Neoplasms (Liver Cancer)
08/2023 - 12/2013
4Brain Injuries (Brain Injury)
01/2023 - 12/2019
4Dry Eye Syndromes (Dry Eye Syndrome)
01/2023 - 07/2020
4Hepatocellular Carcinoma (Hepatoma)
12/2021 - 03/2008
4Hypercalcemia (Milk Alkali Syndrome)
01/2021 - 01/2016
3COVID-19
02/2024 - 01/2022
3Stroke (Strokes)
01/2024 - 08/2021
3Body Weight (Weight, Body)
12/2023 - 06/2017
3Bites and Stings (Sting)
11/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
04/2024 - 07/2006
28Amyloid (Amyloid Fibrils)IBA
02/2024 - 01/2010
15CytokinesIBA
12/2023 - 04/2012
14Peptides (Polypeptides)IBA
11/2023 - 08/2007
12Small Interfering RNA (siRNA)IBA
05/2024 - 02/2014
11Liposomes (Liposome)IBA
04/2024 - 04/2013
11Amyloid beta-PeptidesIBA
07/2023 - 08/2007
11Paclitaxel (Taxol)FDA LinkGeneric
02/2020 - 03/2008
9Therapeutic UsesIBA
05/2024 - 02/2014
9LigandsIBA
04/2024 - 10/2015
9Antiviral Agents (Antivirals)IBA
02/2024 - 11/2019
9Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2019
9Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2023 - 08/2007
9LipidsIBA
01/2023 - 10/2012
8obinutuzumabIBA
10/2023 - 01/2020
8venetoclaxIBA
10/2023 - 01/2020
7RNA (Ribonucleic Acid)IBA
05/2024 - 01/2020
7Chimeric Antigen ReceptorsIBA
04/2024 - 11/2020
7Calcitriol Receptors (Calcitriol Receptor)IBA
10/2023 - 01/2016
7Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 01/2016
7ChitosanIBA
02/2020 - 10/2009
7MicellesIBA
02/2020 - 10/2009
6AntigensIBA
04/2024 - 01/2006
6CholesterolIBA
12/2023 - 01/2018
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023 - 01/2018
6InterferonsIBA
11/2023 - 11/2019
6GoldIBA
08/2023 - 12/2013
6Messenger RNA (mRNA)IBA
04/2023 - 11/2018
6CalciumIBA
01/2022 - 01/2012
6MicroRNAs (MicroRNA)IBA
01/2021 - 02/2012
5Poly I-CIBA
04/2024 - 01/2019
5Long Noncoding RNAIBA
12/2023 - 01/2021
5PolymersIBA
01/2023 - 05/2015
5SolutionsIBA
01/2023 - 10/2012
4Immune Checkpoint InhibitorsIBA
05/2024 - 01/2022
4HydrogelsIBA
05/2024 - 01/2016
4AntioxidantsIBA
02/2024 - 12/2019
4CollagenIBA
01/2024 - 04/2016
4Coloring Agents (Dyes)IBA
01/2024 - 05/2022
4EnzymesIBA
12/2023 - 08/2016
4Glucose (Dextrose)FDA LinkGeneric
08/2023 - 12/2017
4ibrutinibIBA
05/2023 - 01/2022
4Mitogen-Activated Protein KinasesIBA
10/2022 - 02/2014
4AcidsIBA
08/2021 - 04/2013
4pentaneIBA
12/2018 - 01/2016
3Transcription Factors (Transcription Factor)IBA
05/2024 - 05/2022
3Flavin-Adenine Dinucleotide (FAD)IBA
02/2024 - 03/2014
3OligosaccharidesIBA
02/2024 - 01/2020
32- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
01/2024 - 01/2023
3Biocompatible Materials (Biomaterials)IBA
12/2023 - 06/2023
3Histone Deacetylase 6IBA
11/2023 - 10/2022

Therapy/Procedure

70Therapeutics
05/2024 - 04/2013
17Drug Therapy (Chemotherapy)
05/2024 - 05/2009
9Immunotherapy
05/2024 - 11/2020
7Decompression
01/2023 - 12/2019
4Operative Surgical Procedures
02/2024 - 02/2022
4Radiotherapy
01/2023 - 01/2019
3Resuscitation
01/2024 - 05/2016